Inflammatory processes in complex regional pain syndromes

Immunological Investigations

Volumn 42, Issue 4, 2013, Pages 263-272

  Hauser, Joshua ^a   Hsu, Bernard ^a   Nader, Nader D ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Chronic Pain; Inflammation; Neurogenic; Reflex Sympathetic Distrophy

Indexed keywords

CYTOKINE; ENDOTHELIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COMPLEX REGIONAL PAIN SYNDROME; COMPLEX REGIONAL PAIN SYNDROME TYPE I; COMPLEX REGIONAL PAIN SYNDROME TYPE II; HUMAN; NEUROGENIC INFLAMMATION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL;

ANIMALS; COMPLEX REGIONAL PAIN SYNDROMES; HUMANS; INFLAMMATION; INTERLEUKINS; NEUROPEPTIDES; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875960892     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2013.764317     Document Type: Article

References (43)

1. Backonja, M. M., Coe, C. L., Muller, D. A., and Schell, K. (2008). Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. J. Neuroimmunol. 195 (1-2): 157-163.
2. Beutler, B., Kruys, V. (1995). Lipopolysaccharide signal transduction, regulation of tumor necrosis factor biosynthesis, and signaling by tumor necrosis factor itself. J. Cardiovasc. Pharmacol. 25 Suppl 2: S1-58.
3. Bianchi, C., Rossi, S., Turi, S., Brambilla, A., Felisari, G., Mascheri, D. (2006). Long-term functional outcome measures in corticosteroid-treated complex regional pain syndrome. Eura Medicophys. 42(2): 103-111.
4. Bianchi, R., Citti, L., Beghetti, R., Romani, L., D'incalci, M., Puccetti, P., Fioretti, M. C. (1992). O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents. Cancer Chemother. Pharmacol. 29(4): 277-282.
5. Birklein, F., Handwerker, H. O. (2001). Complex regional pain syndrome: How to resolve the complexity? Pain 94(1): 1-6.
6. Birklein, F., Schmelz, M. (2008). Neuropeptides, neurogenic inflammation and complex regional pain syndrome (crps). Neurosci. Lett. 437(3): 199-202.
7. Blair, S. J., Chinthagada, M., Hoppenstehdt, D., Kijowski, R., Fareed, J. (1998). Role of neuropeptides in pathogenesis of reflex sympathetic dystrophy. Acta Orthop. Belg. 64(4): 448-451.
8. Breder, C. D., Tsujimoto, M., Terano, Y., Scott, D. W., Saper, C. B. (1993). Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system. J. Comp. Neurol. 337(4): 543-567.
9. De Mos, M., De Bruijn, A. G., Huygen, F. J., Dieleman, J. P., Stricker, B. H., Sturkenboom, M. C. (2007). The incidence of complex regional pain syndrome: A population-based study. Pain 129(1-2): 12-20.
10. De Mos, M., Huygen, F. J., Dieleman, J.P., Koopman, J. S., Stricker, B. H., Sturkenboom, M. C. (2008). Medical history and the onset of complex regional pain syndrome (crps). Pain 139(2): 458-466.
11. El-Shazly, A. E., Masuyama, K., Eura, M., Ishikawa, T (1996). Immunoregulatory effect of substance p in human eosinophil migratory function. Immunol. Invest. 25(3): 191-201.
12. Elenkov, I. J., Kovacs, K., Duda, E., Stark, E., Vizi, E. S. (1992). Presynaptic inhibitory effect of tnf-alpha on the release of noradrenaline in isolated median eminence. J. Neuroimmunol. 41(1): 117-120.
13. Fiers W (1991). Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett. 285(2): 199-212.
14. Fiore, M., Alleva, E., Probert, L., Kollias, G., Angelucci, F., Aloe, L. (1998). Exploratory and displacement behavior in transgenic mice expressing high levels of brain tnf-alpha. Physiol. Behav. 63(4): 571-576.
15. Geber, C., Fondel, R., Kramer, H. H., Rolke, R., Treede, R. D., Sommer, C., and Birklein, F. (2007). Psychophysics, flare, and neurosecretory function in human pain models: Capsaicin versus electrically evoked pain. J. Pain 8(6): 503-514.
16. Guo, T. Z., Wei, T., Kingery, W. S. (2006). Glucocorticoid inhibition of vascular abnormalities in a tibia fracture rat model of complex regional pain syndrome type i. Pain 121(1-2): 158-167.
17. Hayley, S., Brebner, K., Lacosta, S., Merali, Z., Anisman, H. (1999). Sensitization to the effects of tumor necrosis factor-alpha: Neuroendocrine, central monoamine, and behavioral variations. J. Neurosci. 19(13): 5654-5665.
18. Holzer, P. (1998). Neurogenic vasodilatation and plasma leakage in the skin. Gen. Pharmacol. 30(1): 5-11.
19. Hunt, J. S., Chen, H. L., Hu, X. L., Chen, T. Y., Morrison, D. C. (1992). Tumor necrosis factor-alpha gene expression in the tissues of normal mice. Cytokine 4(5): 340-346.
20. Huygen, F. J., De Bruijn, A. G., De Bruin, M. T., Groeneweg, J. G., Klein, J., Zijlstra, F. J. (2002). Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm. 11(1): 47-51.
21. Ignatowski, T. A., Gallant, S., Spengler, R. N. (1996). Temporal regulation by adrenergic receptor stimulation of macrophage (m phi)-derived tumor necrosis factor (tnf) production post-lps challenge. J. Neuroimmunol. 65(2): 107-117.
22. Ignatowski, T. A., Noble, B. K., Wright, J. R., Gorfien, J. L., Heffner, R. R., Spengler, R. N. (1997). Neuronal-associated tumor necrosis factor (tnf alpha): Its role in noradrenergic functioning and modification of its expression following antidepressant drug administration. J. Neuroimmunol. 79(1): 84-90.
23. Kalita, J., Vajpayee, A., Misra, U. K. (2006). Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: A randomized controlled trial. QJM 99(2): 89-95.
24. Kielian, T., Esen, N., Bearden, E. D. (2005). Toll-like receptor 2 (tlr2) is pivotal for recognition of s. Aureus peptidoglycan but not intact bacteria by microglia. Glia 49(4): 567-576.
25. Kingery, W. S., Davies, M. F., Clark, J. D. (2003). A substance p receptor (nk1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type ii. Pain 104(1-2): 75-84.
26. Kramer, H. H., Eberle, T., Uceyler, N., Wagner, I., Klonschinsky, T., Muller, L. P., Sommer, C, Birklein, F. (2011). Tnf-alpha in crps and 'normal' trauma-significant differences between tissue and serum. Pain 152(2): 285-290.
27. Liu, T., Clark, R. K., Mcdonnell, P. C, Young, P. R., White, R. F., Barone, F. C, Feuerstein, G. Z. (1994). Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25(7): 1481-1488.
28. Marinus, J., Moseley, G. L., Birklein, F., Baron, R., Maihofner, C, Kingery, W. S., Van Hilten, J. J. (2011). "Clinical features and pathophysiology of complex regional pain syndrome." Lancet Neurol. 10(7): 637-648.
29. Mujenda, F. H., Duarte, A. M., Reilly, E. K., Strichartz, G. R. (2007). Cutaneous endothelin-a receptors elevate post-incisional pain. Pain 133(1-3): 161-173.
30. Munnikes, R. J., Muis, C, Boersma, M., Heijmans-Antonissen, C, Zijlstra, F. J., Huygen, F. J. (2005). Intermediate stage complex regional pain syndrome type 1 is unrelated to proinflammatory cytokines. Mediators Inflamm. 2005(6): 366-372.
31. Oka, T., Wakugawa, Y., Hosoi, M., Oka, K., Hori, T. (1996). Intracerebroventricular injection of tumor necrosis factor-alpha induces thermal hyperalgesia in rats. Neuroimmunomodulation 3(2-3): 135-140.
32. Pauli, S., Linthorst, A. C, Reul, J. M. (1998). Tumour necrosis factor-alpha and interleukin-2 differentially affect hippocampal serotonergic neurotransmission, behavioural activity, body temperature and hypothalamic-pituitary-adrenocortical axis activity in the rat. Eur. J. Neurosci. 10(3): 868-878.
33. Sabsovich, I., Guo, T. Z., Wei, T., Zhao, R., Li, X., Clark, D. J., Geis, C, Sommer, C, Kingery, W. S. (2008). Tnf signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type i. Pain 137(3): 507-519.
34. Sandroni, P., Benrud-Larson, L. M., Mcclelland, R. L., Low, P. A. (2003). Complex regional pain syndrome type i: Incidence and prevalence in olmsted county, a population-based study. Pain 103(1-2): 199-207.
35. Schinkel, C, Gaertner, A., Zaspel, J., Zedler, S., Faist, E., Schuermann, M. (2006). Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. Clin. J. Pain 22(3): 235-239.
36. Taskaynatan, M. A., Ozgul, A., Tan, A. K., Dincer, K., Kalyon, T. A. (2004). Bier block with methylprednisolone and lidocaine in crps type i: A randomized, double-blinded, placebo-controlled study. Reg. Anesth. Pain Med. 29(5): 408-412.
37. Van De Beek, W. J., Remarque, E. J., Westendorp, R. G., Van Hilten, J. J. (2001). Innate cytokine profile in patients with complex regional pain syndrome is normal. Pain 91(3): 259-261.
38. Van Der Kleij, H. P., Ma, D., Redegeld, F. A., Kraneveld, A. D., Nijkamp, F. P., Bienenstock, J. (2003). "Functional expression of neurokinin 1 receptors on mast cells induced by il-4 and stem cell factor." J. Immunol. 171(4): 2074-2079.
39. Weber, M., Birklein, F. (2001). Complex regional pain syndrome: An actual survey. Expert Rev. Neurother. 1(1): 100-109.
40. Wesseldijk, F., Huygen, F. J., Heijmans-Antonissen, C, Niehof, S. P., Zijlstra, F. J. (2008a). Six years follow-up of the levels of tnf-alpha and il-6 in patients with complex regional pain syndrome type 1. Mediators Inflamm. 2008: 1-7.
41. Wesseldijk F, Huygen, FJ, Heijmans-Antonissen, C, Niehof, SP and Zijlstra, FJ (2008b). "Tumor necrosis factor-alpha and interleukin-6 are not correlated with the characteristics of complex regional pain syndrome type 1 in 66 patients." Eur J Pain 12(6): 716-721.
42. Yamada K, Iida, R, Miyamoto, Y, Saito, K, Sekikawa, K, Seishima, M and Nabeshima, T (2000). "Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-alpha gene: Implications for emotional behavior." J Neuroimmunol 111(1-2): 131-138.
43. Zyluk A (1998). "Results of the treatment of posttraumatic reflex sympathetic dystrophy of the upper extremity with regional intravenous blocks of methylprednisolone and lidocaine." Acta Orthop Belg 64(4): 452-456.